期刊文献+

续断壮骨胶囊治疗原发性骨质疏松症的Ⅲ期临床试验研究 被引量:7

Phase Ⅲ clinical investigation of XuDuanZhuangGu capsules to the primary osteoporotic patient
下载PDF
导出
摘要 目的确证续断壮骨胶囊治疗原发性骨质疏松症的临床有效性和安全性。方法采用多中心、随机、双盲、安慰剂和阳性药物平性对照的试验设计,将合格受试者以3:1:1的比例分配至治疗组、两个对照组。进行为期6个月的治疗和观察。结果续断壮骨胶囊对腰椎、股骨颈、Ward三角、大粗隆等部位的骨矿密度有明显改善,与安慰组比较差异均具有统计学意义(P〈0.05)。在中医证候的改善方面,续断壮骨胶囊明显优于阳性对照组、安慰剂组,均有统计学意义。治疗期间肝肾功能、血常规、尿常规均无明显异常。结论续断壮骨胶囊能有效提高骨密度,缓解腰背疼痛等症状,疗效好,副作用小,可用于治疗骨质疏松症。 Objective Further comments XuDuanZhuangGu capsule treatment of osteoporosis clinical efficacy and safety. Methods A multicenter, randomized, double-blind, placebo and positive control of the drug-test design, the subjects will be allocated to the ratio of 3 : 1 : 1 to the treatment group, two control group. For a six-month treatment and observation. Results XuDuanZhuanggGu capsule on the L2-4, Neck, Wards, Troch of BMD has improved significantly, as compared with the comfort have statistically significant differences( P 〈 0.05). TCM Syndrome in the improvements, XuDuanZhuangGu capsule is superior to the positive control group, two placebo group, have statistical significance. During the treatment of liver and kidney function, blood, urine routine presented no significant abnormalities. Conclusion XuDuanZhuangGu capsule can improve BMD, ease back pain etc., good effects, mild after-effect, can be used for treatment of osteoporosis.
出处 《中国骨质疏松杂志》 CAS CSCD 2009年第3期197-200,共4页 Chinese Journal of Osteoporosis
基金 国家高技术研究发展计划(863计划)重大专项项目(2003AA2Z3263、2004AA2Z3B40) “中医骨伤科学”国家重点学科(100508) 上海市重点学科(T0303)
关键词 续断壮骨胶囊 骨质疏松症 临床试验 XuDuanZhuangGu Capsules Osteoporosis Clinical investigation
  • 相关文献

参考文献9

二级参考文献48

共引文献797

同被引文献112

引证文献7

二级引证文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部